当前位置:首页 - 行情中心 - 泰林生物(300813) - 财务分析

泰林生物

(300813)

  

流通市值:25.90亿  总市值:41.28亿
流通股本:7605.11万   总股本:1.21亿

泰林生物(300813)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润0.13亿元,每股收益0.11元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益81021.49万元,未分配利润25213.76万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产92682.78万元,负债11661.30万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入145,825,607.266,938,979.3348,998,253.03242,467,278.88
营业总成本132,729,520.462,864,064.42348,161,065.58236,221,850.45
其他经营收益
营业利润13,633,704.194,047,379.9312,398,740.8512,850,755.64
利润总额13,098,032.473,518,979.7412,766,485.0112,595,272.15
净利润13,342,711.073,327,916.5212,253,626.7210,599,894.14
每股收益
其他综合收益----
综合收益总额13,342,711.073,327,916.5212,253,626.7210,599,894.14
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计589,772,263.36614,873,640.83632,761,878.52636,321,857.58
非流动资产:
非流动资产合计337,055,563.05324,145,683.01327,146,049.55325,767,216.59
资产总计926,827,826.41939,019,323.84959,907,928.07962,089,074.17
流动负债:
流动负债合计113,558,894.51112,047,540.31135,785,102.66141,271,713.73
非流动负债:
非流动负债合计3,054,070.833,393,283.593,393,283.59165,212,719.95
负债合计116,612,965.34115,440,823.9139,178,386.25306,484,433.68
所有者权益(或股东权益):
归属于母公司股东权益合计810,214,861.07823,578,499.94820,050,345.31654,843,177.53
股东权益合计810,214,861.07823,578,499.94820,729,541.82655,604,640.49
负债和股东权益合计926,827,826.41939,019,323.84959,907,928.07962,089,074.17
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计156,857,938.2670,093,446.06355,695,474.12233,795,795.59
经营活动现金流出小计153,737,251.9180,830,967.33331,038,859.93254,510,790.13
经营活动产生的现金流量净额3,120,686.35-10,737,521.2724,656,614.19-20,714,994.54
投资活动产生的现金流量:
投资活动现金流入小计596,652,600.71472,400,165.74708,157,690.05569,235,804.24
投资活动现金流出小计570,481,203.12379,891,445.61750,538,053.63540,813,362.92
投资活动产生的现金流量净额26,171,397.5992,508,720.13-42,380,363.5828,422,441.32
筹资活动产生的现金流量:
筹资活动现金流入小计11,174,000-15,645,426.715,645,426.7
筹资活动现金流出小计39,469,156.5327,343,552.7226,108,435.7910,920,399.29
筹资活动产生的现金流量净额-28,295,156.53-27,343,552.72-10,463,009.094,725,027.41
汇率变动对现金及现金等价物的影响-96,942.5822,175.92135,328.6-151,083.9
现金及现金等价物净增加额899,984.8354,449,822.06-28,051,429.8812,281,390.29
期末现金及现金等价物余额70,778,067.29124,327,904.5269,878,082.46110,182,347.05
补充资料:
现金及现金等价物的净增加额899,984.83--28,051,429.88-
TOP↑